GENOSS Coronary Stent Clinical Trial
Ischemic Heart Disease
About this trial
This is an interventional treatment trial for Ischemic Heart Disease focused on measuring coronary stent, ischemic heart disease, acute coronary syndrome
Eligibility Criteria
Inclusion Criteria:
① Subject must be at least 19 years of age
② Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily.
③ Patients with stable coronary artery disease or acute coronary syndrome and at least one lesion with greater than 50% diameter stenosis suitable for stent implantation
Exclusion Criteria:
Pregnant women ② Patients unable to provide consent, ③ Patients with known intolerance to aspirin, clopidogrel, ticagrelor, prasugrel, heparin or components of drug-eluting stents (sirolimus or everolimus)
- Patients who have non-cardiac co-morbid conditions with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment)
Sites / Locations
- Cardiac and Vascular Center; Samsung Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
GENOSS stent arm
XIENCE stent arm
Coronary lesions of the subjects this arm will be treated with GENOSS stent when in need of stent implantation
Coronary lesions of the subjects this arm will be treated with Xience stent when in need of stent implantation